title: An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
abstract: Antibody-drug conjugates (ADCs) are complex therapeutic agents that use the specific targeting properties of antibodies and the highly potent cytotoxicity of small molecule drugs to selectively eliminate tumor cells while limiting the toxicity to normal healthy tissues. Two critical quality attributes of ADCs are the purity and stability of the active small molecule drug linked to the ADC, but these are difficult to assess once the drug is conjugated to the antibody. In this study, we report a enzyme deconjugation approach to cleave small molecule drugs from ADCs, which allows the drugs to be subsequently characterized by reversed-phase high performance liquid chromatography. The model ADC we used in this study utilizes a valine-citrulline linker that is designed to be sensitive to endoproteases after internalization by tumor cells. We screened several proteases to determine the most effective enzyme. Among the 3 cysteine proteases evaluated, papain had the best efficiency in cleaving the small molecule drug from the model ADC. The deconjugation conditions were further optimized to achieve complete cleavage of the small molecule drug. This papain deconjugation approach demonstrated excellent specificity and precision. The purity and stability of the active drug on an ADC drug product was evaluated and the major degradation products of the active drug were identified. The papain deconjugation method was also applied to several other ADCs, with the results suggesting it could be applied generally to ADCs containing a valine-citrulline linker. Our results indicate that the papain deconjugation method is a powerful tool for characterizing the active small molecule drug conjugated to an ADC, and may be useful in ensuring the product quality, efficacy and the safety of ADCs.
authors.affiliation: a Small Molecule Pharmaceutical Sciences, Genentech , 1 DNA Way, South San Francisco , CA , USA.
authors.forename: Yi
authors.initials: Y
authors.lastname: Li
authors.affiliation: a Small Molecule Pharmaceutical Sciences, Genentech , 1 DNA Way, South San Francisco , CA , USA.
authors.forename: Christine
authors.initials: C
authors.lastname: Gu
authors.affiliation: a Small Molecule Pharmaceutical Sciences, Genentech , 1 DNA Way, South San Francisco , CA , USA.
authors.forename: Jason
authors.initials: J
authors.lastname: Gruenhagen
authors.affiliation: a Small Molecule Pharmaceutical Sciences, Genentech , 1 DNA Way, South San Francisco , CA , USA.
authors.forename: Peter
authors.initials: P
authors.lastname: Yehl
authors.affiliation: a Small Molecule Pharmaceutical Sciences, Genentech , 1 DNA Way, South San Francisco , CA , USA.
authors.forename: Nik P
authors.initials: NP
authors.lastname: Chetwyn
authors.affiliation: a Small Molecule Pharmaceutical Sciences, Genentech , 1 DNA Way, South San Francisco , CA , USA.
authors.forename: Colin D
authors.initials: CD
authors.lastname: Medley
mesh_terms: D000911:Antibodies, Monoclonal / Q000032:analysis*; D000970:Antineoplastic Agents / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D056148:Chromatography, Reverse-Phase / Q000379:methods; D006801:Humans; D018796:Immunoconjugates / Q000032:analysis* / Q000737:chemistry; D010206:Papain / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D018796:Immunoconjugates; D010206:Papain
keywords: Antibody-Drug conjugate; HPLC; enzyme deconjugation; mass spectrometry; small molecule pharmaceutical analysis